Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) Return on Sales (2020 - 2025)

Historic Return on Sales for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to 0.95%.

  • Stemtech's Return on Sales rose 1800.0% to 0.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.79%, marking a year-over-year increase of 2300.0%. This contributed to the annual value of 0.75% for FY2024, which is 3600.0% up from last year.
  • As of Q3 2025, Stemtech's Return on Sales stood at 0.95%, which was up 1800.0% from 0.42% recorded in Q2 2025.
  • Stemtech's Return on Sales' 5-year high stood at 16.61% during Q3 2022, with a 5-year trough of 19.56% in Q2 2022.
  • Over the past 5 years, Stemtech's median Return on Sales value was 0.75% (recorded in 2021), while the average stood at 1.15%.
  • Within the past 5 years, the most significant YoY rise in Stemtech's Return on Sales was 224600bps (2022), while the steepest drop was -188100bps (2022).
  • Stemtech's Return on Sales (Quarter) stood at 0.65% in 2021, then increased by 22bps to 0.5% in 2022, then plummeted by -173bps to 1.37% in 2023, then soared by 78bps to 0.3% in 2024, then crashed by -216bps to 0.95% in 2025.
  • Its last three reported values are 0.95% in Q3 2025, 0.42% for Q2 2025, and 1.68% during Q1 2025.